SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andreas Kronbichler, David R. W. Jayne, Gert Mayer, Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis, European Journal of Clinical Investigation, 2015, 45, 3
  2. 2
    Mary Jane Burton, Jeffrey R Curtis, Shuo Yang, Lang Chen, Jasvinder A Singh, Ted R Mikuls, Kevin L Winthrop, John W Baddley, Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study, Arthritis Research & Therapy, 2015, 17, 1

    CrossRef

  3. 3
    Worawit Louthrenoo, Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases, Best Practice & Research Clinical Rheumatology, 2015,

    CrossRef

  4. 4
    Blanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, Aitziber Illaro, Emilio Fábrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menéndez, Joaquín Cabezas, Javier Crespo, Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project, Hepatology, 2014, 60, 1
  5. 5
    Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego, Extrahepatic manifestations of chronic hepatitis C virus infection, Digestive and Liver Disease, 2014, 46, S165

    CrossRef

  6. 6
    Anil Seetharam, Robert Perrillo, Robert Gish, Immunosuppression in Patients with Chronic Hepatitis B, Current Hepatology Reports, 2014, 13, 3, 235

    CrossRef

  7. 7
    Françoise Lunel-Fabiani, Charles Masson, Alexandra Ducancelle, Maladies systémiques et biomédicaments : comprendre, apprécier et prévenir le risque de réactivation d’hépatite B, Revue du Rhumatisme, 2014, 81, 5, 374

    CrossRef

  8. 8
    Françoise Lunel-Fabiani, Charles Masson, Alexandra Ducancelle, Systemic diseases and biotherapies: Understanding, evaluating, and preventing the risk of hepatitis B reactivation, Joint Bone Spine, 2014, 81, 6, 478

    CrossRef

  9. 9
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef